About TandemLife
TandemLife is a company based in Pittsburgh (United States) founded in 1996 by George Magovern was acquired by LivaNova in February 2018. TandemLife has raised $33 million across 1 funding round from investors including LivaNova and NeoMed. TandemLife offers products and services including LifeSPARC System, ProtekDuo, TandemHeart, TandemLung, and TandemLife. TandemLife operates in a competitive market with competitors including Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.
- Headquarter Pittsburgh, United States
- Founders George Magovern
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Livanova, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TandemLife
TandemLife offers a comprehensive portfolio of products and services, including LifeSPARC System, ProtekDuo, TandemHeart, TandemLung, and TandemLife.
Provides advanced support for critical care patients during procedures.
Enables dual circulatory assistance in medical interventions.
Offers temporary heart support for surgical and emergency use.
Assists lung function in critical respiratory conditions.
Combines heart and lung support for comprehensive care.
Includes essentials for circulatory support procedures and setups.
People of TandemLife
Unlock access to complete
Unlock access to complete
Software Development Team
61 people
Leadership Team
27 people
Finance and Accounting
25 people
Human Resources and Administration
23 people
Operations Team
15 people
Data Analysis and Operations Team
12 people
Sales and Marketing
10 people
Legal and Compliance
8 people
Unlock access to complete
Funding Insights of TandemLife
TandemLife has successfully raised a total of $33M through 1 strategic funding round. The most recent funding activity was a Series C round of $33 million completed in February 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TandemLife
TandemLife has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include LivaNova and NeoMed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic life sciences-focused VC firm investing in North America & Europe
|
Locked | Locked | Locked | |
|
Therapeutic devices for cardiac and neurological conditions are provided worldwide.
|
Locked | Locked | Locked |
Investor details for TandemLife
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TandemLife
Investment portfolio details for TandemLife
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TandemLife
Detailed financials for TandemLife
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tandemlife Comparisons
Peer comparison for TandemLife
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TandemLife
TandemLife operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Implantable technology for hypertension and heart failure is developed.
|
|
| Locked | Locked | Locked |
Miniaturized ventricular assist devices are developed for heart failure treatment.
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
|
| Locked | Locked | Locked |
Total artificial hearts are developed for cardiac replacement therapy.
|
Detailed competitors of TandemLife
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tandemlife
Complete news archive for TandemLife
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TandemLife
TandemLife was founded in 1996 and raised its 1st funding round 5 years after it was founded.
TandemLife is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
John Marous is the current CEO of TandemLife.
TandemLife is a funded company, having raised a total of $33M across 1 funding round to date.
TandemLife, founded in 1996 and based in Pittsburgh, United States, operates in the cardiovascular medical device sector. Temporary ventricular circulatory support devices for post-cardiotomy cardiac failure are developed, along with a Tandem Lung oxygenator for blood oxygenation and carbon dioxide removal. Hydrodynamic centrifugal pumps, transseptal cannulas for left ventricular assist, and electromechanical systems are also produced. The company rebranded from CardiacAssist in 2016.
TandemLife's top competitors include Sequana Medical, CVRx and Adona Medical.
TandemLife offers LifeSPARC System, ProtekDuo, TandemHeart, TandemLung, and 2 more products and services.